April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 23, 2026
Based on our research, the biotechnology based chemicals market was valued at USD 109.53 billion in 2025 and reached USD 120.09 billion in 2026, and it is projected to grow significantly to approximately USD 274.93 billion by 2035, registering a CAGR of 9.64% during the forecast period....
January 19, 2026
According to market projections, the APAC viral vector and plasmid DNA manufacturing sector is expected to grow from USD 1.68 billion in 2025 to USD 12.22 billion by 2035, reflecting a CAGR of 21.93%. In 2024, the APAC viral vector and plasmid DNA manufacturing market saw adeno-associated viruses dominate by vector type, while cancer led by di...
January 15, 2026
Our projections indicate that, the global gene knockout cell line construction service market will increase from USD 2.1 billion in 2025 to USD 3.56 billion by 2035, experiencing a CAGR of 5.44% over the next 10 years. Developing disease modeling and diverse therapies are fueling the global market expansion. North America led the market due to the ...
January 08, 2026
Projections indicate that, metagenomics industry is projected to rise from USD 2.68 billion in 2025 to USD 9.55 billion by 2035, reflecting a CAGR of 13.55% over the next decade. The metagenomics market is expanding due to the growing incidence of infectious diseases as well as rising advancements in metagenomics. North America led the market due t...
January 08, 2026
Based on market forecasts, the DNA polymerase sector will expand from USD 419.87 million in 2025 to USD 769.12 million by 2035, experiencing a CAGR of 6.24%.The DNA polymerase market is expanding due to growing demand for diagnostic applications as well as advancements in PCR techniques. North America led the market due to the presence of an advanc...
January 07, 2026
Market insights predict the global small scale bioreactors industry will increase from USD 2.63 billion in 2025 to USD 10.49 billion by 2035, achieving a CAGR of 14.84%. The growing demand for biopharmaceuticals and technological advancements drives the market. North America led the global market due to the presence of key players and favorable gov...
January 07, 2026
Based on market forecasts, the western blotting sector will expand from USD 2.13 billion in 2025 to USD 3.84 billion by 2035, experiencing a CAGR of 6.05%. The increasing prevalence of chronic disorders and technological advancements drive the market. North America dominated the global market owing to the presence of key players and increasing rese...
January 06, 2026
According to market projections, the liquid biopsy sector is expected to grow from USD 7.08 billion in 2025 to USD 27.42 billion by 2035, reflecting a CAGR of 14.5%, driven by the need for non-invasive cancer diagnostics. It enables real-time monitoring, early detection, and personalized treatment. Advances in NGS, ctDNA analysis, and AI are enhanc...
January 06, 2026
Market insights predict, the U.S. next generation sequencing industry is expected to grow from USD 2.85 billion in 2025 to USD 12.52 billion by 2035, driven by a CAGR of 15.95%. The growing demand for personalized medicines and the increasing adoption of advanced technologies drive the market....
January 02, 2026
Projections indicate that, the global plasmid DNA manufacturing market will increase from USD 2.61 billion in 2025 to USD 14.59 billion by 2035, experiencing a CAGR of 18.77% over the next 10 years. Plasmid DNA is highly valuable in conducting research, studying diseases, studying gene mutations, repairing genetic material, and developing GMOs for ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com